Russian pharma strategy cheers domestic firms but is criticised by state purse-keeper
This article was originally published in RAJ Devices
Executive Summary
The Russian ministry for economy and energy has finalised the draft: “Strategy for the development of the pharmaceutical industry in the Russian Federation until 2020”, on which it has been working since the beginning of this year. The draft – presently being discussed by the country’s cabinet – has already been criticised by the ministry of finance, raising fears among domestic drug manufacturers that the Russian pharmaceutical industry will not see any significant results from the document’s implementation.